Zevalin-BEAM or Zevalin as consolidation in patients with transformed lymphoma.
Recruiting
- Conditions
- transformed B-cell non-Hodgkin's lymphoma
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 58
Inclusion Criteria
1. First diagnosis of transformation of lymphoma;
2. Histologically confirmed CD20 positive transformed B cell NHL lymphoma, according to the WHO classification 2008, stage I-IV;
Exclusion Criteria
1. Known hypersensitivity to murine antibodies or proteins;
2. Presence of any other active neoplasms or history of prior malignancy, except non-melanoma skin tumours or stage 0 (in situ) cervical carcinoma during the past 5 years;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method